Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

How a key brain network responds to seasonal shifts in day length

A recent paper examined the difference in neuronal communication in the hypothalamic network that regulates physiological function in response to the photoperiod.

8 Sep 2022

Study sheds light on how seasonal changes in day length alter the brain and subsequent behavior

Seasonal changes in light -; longer days in summer, shorter in winter -; have long been associated with human behaviors, affecting everything from sleep and eating patterns to brain and hormonal activity.

2 Sep 2022

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

2 Sep 2022

Case report describes clinical manifestation of monkeypox, SARS-CoV-2, and HIV coinfection

Scientists have recently presented the first documented case of coinfection with monkeypox virus, SARS-CoV-2, and HIV.

23 Aug 2022

Tiny, touch-based sensor rapidly detects lithium levels from sweat on the surface of a fingertip

Lithium can alleviate the symptoms of bipolar disorder and depression -; if taken in just the right amount.

22 Aug 2022

Metabolic Mind Award Program recognizes champions in the emerging field of metabolic psychiatry

The Baszucki Brain Research Fund and the Milken Institute's Center for Strategic Philanthropy today announced the launch of the Metabolic Mind Award Program, recognizing champions working at the intersection of metabolism and mental health in the emerging field of metabolic psychiatry. This year's award focus will be on Ketogenic Metabolic Therapy for mental health.

18 Aug 2022

BBRF hosts a free webinar on manipulating memories to help treat brain illness

The Brain & Behavior Research Foundation is hosting a free webinar, "Manipulating Memories to Help Treat Brain Illness" on Tuesday, August 9, 2022, at 2:00 pm EDT.

3 Aug 2022

PCORI approves $258 million funding to support 26 new health care-related studies

The Patient-Centered Outcomes Research Institute has approved funding awards totaling $258 million to support 26 new research studies.

26 Jul 2022

$50 million PCORI funding approved for studies focused on treating suicidal depression and bipolar depression

Research teams at Mass General Brigham's founding members, Brigham and Women's Hospital and Massachusetts General Hospital, have been approved for more than $50 million in funding awards by the Patient-Centered Outcomes Research Institute for studies focused on treating two important mental health conditions.

26 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Gun safety ‘wrapped in a mental health bill’: A look at health provisions in the new law

The gun safety law forged through tense bipartisan talks in the Senate last month has been heralded as the first federal legislation in 30 years to combat rising gun violence. But what often falls below the radar is the new law's focus on improving mental health services.

7 Jul 2022

New therapy approaches can help when medicine is not enough for schizophrenia and psychosis

The Brain & Behavior Research Foundation is hosting a free webinar, "When Medicine is Not Enough for Schizophrenia and Psychosis" on Tuesday, July 12, 2022, at 2:00 pm EDT.

30 Jun 2022

People with mental health problems at higher risk for severe COVID-19 outcomes

In a recent study published in the CDC’s Emerging Infectious Diseases journal, researchers assessed the associations between mental health conditions (MHCs) and severe outcomes of coronavirus disease 2019 (COVID-19).

15 Jun 2022

Taking valproic acid during pregnancy can cause birth defects, study shows

Valproic acid-; a drug used to treat epilepsy, migraine, and bipolar disorder-; can cause birth defects when taken during pregnancy.

14 Jun 2022

Long wait for justice: People in jail face delays for mental health care before they can stand trial

Beau Hampton’s long wait for psychiatric treatment began last year, after he was accused of attacking his foster father and charged with a misdemeanor.

10 Jun 2022

Discovery of small protein’s structure could lead to new therapies for neurological disorders

Scientists have, for the first time, revealed at the atomic level the structure of a protein that carries one of the body's most important neurotransmitters into neurons.

8 Jun 2022

Prenatal exposure to antiseizure drugs associated with risk of autism and intellectual disability

Women with epilepsy often need medication to prevent seizures during pregnancy. Previous studies have found an association between exposure to the antiseizure medication valproate during pregnancy and risk of autism and low IQ in the offspring.

2 Jun 2022

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia.

1 Jun 2022

Autistic adults have worse health and poorer quality healthcare

Autistic individuals are more likely to have chronic mental and physical health conditions, suggests new research from the University of Cambridge. Autistic individuals also report lower quality healthcare than others.

27 May 2022

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a new study from Massachusetts General Hospital finds that treating psychiatric disorders with psychotropic medications in children and adolescents does not increase the risk of developing substance use, misuse, or substance use disorder (SUD).

19 May 2022

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

How a key brain network responds to seasonal shifts in day length

Study sheds light on how seasonal changes in day length alter the brain and subsequent behavior

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Case report describes clinical manifestation of monkeypox, SARS-CoV-2, and HIV coinfection

Tiny, touch-based sensor rapidly detects lithium levels from sweat on the surface of a fingertip

Metabolic Mind Award Program recognizes champions in the emerging field of metabolic psychiatry

BBRF hosts a free webinar on manipulating memories to help treat brain illness

PCORI approves $258 million funding to support 26 new health care-related studies

$50 million PCORI funding approved for studies focused on treating suicidal depression and bipolar depression

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Gun safety ‘wrapped in a mental health bill’: A look at health provisions in the new law

New therapy approaches can help when medicine is not enough for schizophrenia and psychosis

People with mental health problems at higher risk for severe COVID-19 outcomes

Taking valproic acid during pregnancy can cause birth defects, study shows

Long wait for justice: People in jail face delays for mental health care before they can stand trial

Discovery of small protein’s structure could lead to new therapies for neurological disorders

Prenatal exposure to antiseizure drugs associated with risk of autism and intellectual disability

Stem cell model could provide insights into biological mechanisms that underlie neuropsychiatric disorders

Autistic adults have worse health and poorer quality healthcare

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in